Back to Search Start Over

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies.

Authors :
Cale EM
Shen CH
Olia AS
Radakovich NA
Rawi R
Yang Y
Ambrozak DR
Bennici AK
Chuang GY
Crooks ED
Driscoll JI
Lin BC
Louder MK
Madden PJ
Messina MA
Osawa K
Stewart-Jones GBE
Verardi R
Vrakas Z
Xie D
Zhang B
Binley JM
Connors M
Koup RA
Pierson TC
Doria-Rose NA
Kwong PD
Mascola JR
Gorman J
Source :
Cell reports [Cell Rep] 2024 Dec 24; Vol. 43 (12), pp. 115010. Date of Electronic Publication: 2024 Dec 14.
Publication Year :
2024

Abstract

Antibodies that target the gp120-gp41 interface of the HIV-1 envelope (Env) trimer comprise a commonly elicited category of broadly neutralizing antibodies (bNAbs). Here, we isolate and characterize VRC44, a bNAb lineage with up to 52% neutralization breadth. The cryoelectron microscopy (cryo-EM) structure of antibody VRC44.01 in complex with the Env trimer reveals binding to the same gp120-gp41 interface site of vulnerability as antibody 35O22 from a different HIV-1-infected donor. In addition to having similar angles of approach and extensive contacts with glycans N88 and N625, VRC44 and 35O22 derive from the same IGHV1-18 gene and share convergent mutations, indicating these two antibodies to be members of the only known highly glycan-dependent multidonor class. Strikingly, both lineages achieved almost 100% neutralization breadth against virus strains displaying high-mannose glycans. The high breadth and reproducible elicitation of VRC44 and 35O22 lineages validate germline-based methods of immunogen design for targeting the HIV-1 gp120-gp41 interface.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2024. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
2211-1247
Volume :
43
Issue :
12
Database :
MEDLINE
Journal :
Cell reports
Publication Type :
Academic Journal
Accession number :
39675002
Full Text :
https://doi.org/10.1016/j.celrep.2024.115010